Search
Search Results
##search.searchResults.foundPlural##
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2319PDF: 1340HTML: 17093Bassan Fig.1: 147Bassan Fig.2: 160Bassan Fig.4: 142Fig.3: 196 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3776PDF: 1595HTML: 8052Randi Fig: 188 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
77PDF: 92HTML: 4 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2008PDF: 822HTML: 226 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3259PDF: 1026HTML: 2033 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3177PDF: 978HTML: 3137flowcytometric result of peripheral blood sample: 186 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2836PDF: 1099HTML: 122 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1670PDF: 1250HTML: 266 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1268PDF: 1017HTML: 225 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2254PDF: 1059HTML: 1989Characteristic of study group: 208 -
ADVANCES IN THE TREATMENT OF MALARIA
2876PDF: 1310HTML: 6002 -
WHAT ARE FUNGAL INFECTIONS?
4248PDF: 2417HTML: 27632de Pauw: 244 -
EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS
3158PDF: 989HTML: 1909Untitled: 172Untitled: 176Untitled: 171Untitled: 176Untitled: 174 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2225PDF: 1177HTML: 2595Study of serum haptoglobin level in thalassemia: 352Figures: 185 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
219PDF: 242Suppl. Files: 41HTML: 22 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
897PDF: 744HTML: 123 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2455PDF: 874HTML: 2463 -
Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples
1210PDF: 491HTML: 1168Amato1: 172Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 245jdoe, : 252Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 162 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1997PDF: 776HTML: 702 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2301PDF: 1645HTML: 276 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3301PDF: 1556HTML: 452 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4157PDF: 1017HTML: 19178 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1590PDF: 857HTML: 1039Picture 1: 173 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1392PDF: 1001HTML: 353 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
830PDF: 544HTML: 4026 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1277PDF: 772HTML: 320 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4455PDF: 1650HTML: 4060Tables and Images: 233







